- The trend backdrop is active with a 2-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
EAH
LSE
Week ended 02 Oct 2026
Weekly Investor Report
ECO Animal Health Group plc · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
0.98 GBP
-0.5%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 2.3% above the Trend Line and sits at 52.5% of its 52-week range. The latest completed week returned -0.5%, after a 0.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.
Setup score
54
out of 100
Latest Close
0.98 GBP
2 Oct 2026
1W Return
-0.5%
latest completed week
4W Return
0.0%
short-term follow-through
12W Return
11.4%
quarterly tape
Trend Breadth
51.9%
27 of 52 weeks active
Volume Ratio
2.3x
vs 13-week average
- Next-week expectancy is negative at 33.94% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.5%
Latest completed week; four-week move 0.0%.
Indicator stack
35/65
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 33.94%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 2.3% above the Trend Line and sits at 52.5% of its 52-week range. The latest completed week returned -0.5%, after a 0.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.3x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
28 Aug
4 Sep
11 Sep
18 Sep
25 Sep
2 Oct
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5012-week average 0.33
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.50Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.0% over four weeks, 11.4% over 12 weeks, and 4.3% over one year. The current trend has remained active for 2 consecutive weeks.
Performance by holding period
Active trend streak2 weeks
Active weeks in one year27
Trend breadth51.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.80Latest activity-pressure read.
Pressure change13.6%Four-week change in activity pressure.
Leadership-0.60Latest relative-leadership reading.
RS change85.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 02 Oct 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 75%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength68/100Blend of value, momentum, and quality. Underlying universe rank 33; rank 1 is best.
Value63/100Relative valuation strength. Underlying universe rank 38; rank 1 is best.
Quality64/100Profitability and accounting quality. Underlying universe rank 37; rank 1 is best.
Momentum63/100Medium-term price momentum. Underlying universe rank 38; rank 1 is best.
Growth64/100Revenue and earnings growth. Underlying universe rank 37; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework24/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- - Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 48.6% Gross profit retained from each unit of revenue.
- Operating margin
- 6.5% Operating profit retained from revenue.
- Free-cash-flow margin
- 4.4% Free cash flow generated from revenue.
- Return on invested capital
- 5.8% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 10.0% Latest one-year revenue growth.
- EPS growth
- 35.2% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -28.8% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 8/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- - Net share repurchases relative to market value.
- Shareholder yield
- - Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -2.4x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 4 relevant articles.
0 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-16.2%Distance below the 52-week high.
13-week volatility5.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
10 Apr
8 May
5 Jun
3 Jul
31 Jul
28 Aug
2 Oct
Weeks higher7 of 2617 weeks finished lower.
Best week+15.4%Week of 24 Jul.
Worst week-7.9%Week of 10 Jul.
Latest week-0.5%Week of 2 Oct.
Shape of recent returns
Strong gains3
Modest gains4
Flat weeks2
Modest losses14
Sharp losses3
Recent vol5.0%13-week weekly-return volatility.
Base vol6.1%52-week weekly-return volatility.
Up/down split20/29Count of positive and negative weeks in the 52-week window.
Average skew6.0% / -3.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Healthcare
4-week rank24 / 78
Group average-2.2%
Trend breadth32.1%
Trend32.1%active weekly trend signals
MD57.7%positive activity pressure
RS32.1%positive relative leadership
Four-week leaders
IndustryGB Drug Manufacturers - Specialty & Generic
4-week rank3 / 9
Group average-4.7%
Trend breadth22.2%
Trend22.2%active weekly trend signals
MD55.6%positive activity pressure
RS22.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape51/100
Trend, activity pressure, participation, and risk combine to a 51/100 tape read.
Indicator analysis42/100Latest 12-week confirmation: trend 2/12, activity pressure 10/12, relative leadership 2/12.
Activity pressure 0.50; No reversal markers Next-Week ExpectancyNegative 33.94%Next-week expectancy is negative with a 33.94% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors64/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 50 SVQF24/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 267.0 of 351 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 4 relevant articles.
ECO Animal Health Group (AIM:EAH) Stock Forecast & Analyst Predictions Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 2 Oct 2026 | 0.98 GBP | -0.5% | 0.9577 GBP | 0.9055 GBP | 0.80 | -0.60 | 763.4K | On |
| 25 Sep 2026 | 0.985 GBP | 2.6% | 0.9558 GBP | 0.9064 GBP | 0.76 | -2.38 | 560.2K | On |
| 18 Sep 2026 | 0.96 GBP | 0.0% | 0.9582 GBP | 0.9074 GBP | 0.63 | -4.81 | 341.1K | Off |
| 11 Sep 2026 | 0.96 GBP | -2.0% | 0.9605 GBP | 0.9084 GBP | 0.72 | -4.83 | 704.8K | Off |
| 4 Sep 2026 | 0.98 GBP | -0.5% | 0.9645 GBP | 0.91 GBP | 0.70 | -4.26 | 407.9K | Off |
| 28 Aug 2026 | 0.985 GBP | -2.5% | 0.9687 GBP | 0.9107 GBP | 0.61 | -3.50 | 82.8K | Off |
| 21 Aug 2026 | 1.01 GBP | 0.0% | 0.9733 GBP | 0.9113 GBP | 0.74 | -0.76 | 214.2K | Off |
| 14 Aug 2026 | 1.01 GBP | 2.5% | 0.9735 GBP | 0.9118 GBP | 0.70 | 0.15 | 74.6K | Off |
| 7 Aug 2026 | 0.985 GBP | -1.5% | 0.9772 GBP | 0.9124 GBP | 0.33 | -3.41 | 35.4K | Off |
| 31 Jul 2026 | 1.00 GBP | -1.0% | 0.9805 GBP | 0.9131 GBP | 0.06 | -1.46 | 335.4K | Off |
| 24 Jul 2026 | 1.01 GBP | 15.4% | 0.9825 GBP | 0.9138 GBP | -0.24 | 0.95 | 354.6K | Off |
| 17 Jul 2026 | 0.875 GBP | -0.6% | 0.9817 GBP | 0.9144 GBP | -0.76 | -11.22 | 114.9K | Off |
| 10 Jul 2026 | 0.88 GBP | -7.9% | 0.985 GBP | 0.9159 GBP | -0.88 | -9.97 | 260.6K | Off |
| 3 Jul 2026 | 0.955 GBP | 7.9% | 0.9913 GBP | 0.9172 GBP | -0.91 | -3.56 | 84.5K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.